Type of Spiritual Experience
A description of the experience
Amifostine is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed under the trade name Ethyol.
amifostine is used therapeutically to reduce the incidence of neutropenia-related fever and infection induced by DNA-binding chemotherapeutic agents including alkylating agents (e.g. cyclophosphamide) and platinum-containing agents (e.g. cisplatin). It is also used to decrease the cumulative nephrotoxicity associated with platinum-containing agents. Amifostine is also indicated to reduce the incidence of xerostomia in patients undergoing radiotherapy for head and neck cancer.
Amifostine was originally indicated to reduce the cumulative renal toxicity from cisplatin in non-small cell lung cancer. However, while nephroprotection was observed, the probability that amifostine could protect tumors could not be excluded. Additional data have shown that amifostine-mediated tumor protection, in any clinical scenario, is unlikely.
On Dec, 14, 2015: 1,380 people reported to have side effects when taking Ethyol. Among them, 5 people (0.36%) have Hallucination.
Time on Ethyol when people have Hallucination :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Hallucination0.00%100.00%0.00%0.00%0.00%0.00%0.00%
On Nov, 18, 2015: 1,380 people reported to have side effects when taking Ethyol. Among them, 8 people (0.58%) have Death.
Time on Ethyol when people have Death :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Death50.00%50.00%0.00%0.00%0.00%0.00%0.00%